NEW YORK , Feb. 11, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of CARGO Therapeutics, Inc. ("Cargo" or the "Company") (NASDAQ: CRGX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

NEW YORK , Feb. 11, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Zentalis Pharmaceuticals, Inc. ("Zentalis" or the "Company") (NASDAQ: ZNTL). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

NEW YORK , Feb. 11, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Grocery Outlet Holding Corp. ("Grocery Outlet" or the "Company") (NASDAQ: GO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

NEW YORK , Feb. 11, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Integral Ad Science Holding Corp. ("IAS" or the "Company") (NASDAQ: IAS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

NEW YORK , Feb. 11, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against ModivCare, Inc. ("ModivCare" or the "Company") (NASDAQ: MODV). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

NEW YORK--(BUSINESS WIRE)-- #creditratingagency--KBRA assigns preliminary ratings to seven classes of mortgage-backed certificates from Angel Oak Mortgage Trust 2025-2 (AOMT 2025-2), a $263.1 million non-prime RMBS transaction. The underlying collateral, comprised of 497 residential mortgages, is characterized by a significant concentration of loans underwritten using alternative income documentation. All the loans are either classified as non-qualified mortgages (57.8%) or exempt (42.2%) from the Ability-to-Repay/Q.

Goldman Sachs downgraded Regenxbio Inc RGNX, citing gene therapy's appeal for wet AMD and diabetic retinopathy is uncertain, as most patients are elderly and newer anti-VEGF treatments offer longer-lasting effects at lower costs.

Shares of Sonos have continued to wobble after a very strong Q1 earnings print, reflecting investors' nervousness after the company's app update fiasco. The company achieved a strong earnings beat in Q1, with its revenue decline of -10% y/y landing much better than the -15% y/y that Wall Street had feared. The company is freshly cutting 12% of its workforce (after already laying off staff last August), aiming for $60-$70 million in annual savings that potentially turn around adjusted EBITDA this year.

Nashville, Tennessee, Feb. 11, 2025 (GLOBE NEWSWIRE) -- American Rebel Holdings, Inc. (NASDAQ: AREB) ("American Rebel" or the "Company"), creator of American Rebel Beer ( americanrebelbeer.com ) and a designer, manufacturer, and marketer of branded safes, personal security and self-defense products and apparel ( americanrebel.com ), is pleased to announce that it has regained compliance with the periodic filing requirement under NASDAQ's listing rules.

Shares of Archer Aviation (ACHR -7.84%) are falling Tuesday. The stock lost 7.3% as of 2:10 p.m.

For mineral companies operating in the United States, the regulatory landscape can be as formidable as the exploration process itself. While some states offer a more streamlined path to production, others present a complex maze of federal oversight that companies must navigate to move their projects forward.

The Army has granted upstart weapons maker Anduril control of one of its highest-profile and long-troubled projects known as the Integrated Visual Augmentation System, founder Palmer Luckey announced in a blog post Tuesday.

The time for active fixed income may have truly arrived. After years of significant active ETF growth, many investors may be more comfortable with an active approach to those funds.

Vanguard has listed a new pair of fixed income index ETFs on the Nasdaq today – the Vanguard Ultra-Short Treasury ETF (VGUS) and the Vanguard 0-3 Month Treasury Bill ETF (VBIL). These funds provide exposure to the U.S. Treasury securities with short durations and low volatility, offering tight bid/ask spreads.

NEW YORK, NY / ACCESS Newswire / February 11, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of American Depositary Receipts ("ADRs") of GSK plc (NYSE:GSK) between February 5, 2020 and August 14, 2022, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed.

Proceeds from 50/50 Raffle to Help Make Hockey More Accessible in Quebec Rogers, NHL, and NHLPA Jointly Contribute First $50,000 to 50/50 Jackpot Raffle Open to All Adults in Quebec from February 11 to 15

New Community Offers Elevated Urban Living in the Heart of Orange County New Community Offers Elevated Urban Living in the Heart of Orange County

Arch Capital Group Ltd. (NASDAQ:ACGL ) Q4 2024 Earnings Conference Call February 11, 2025 11:00 AM ET Company Participants Nicolas Papadopoulo - Chief Executive Officer Francois Morin - Chief Financial Officer and Treasurer Conference Call Participants Elyse Greenspan - Wells Fargo Michael Zaremski - BMO Capital Markets Jamminder Bhullar - JPMorgan Wes Carmichael - Autonomous David Motemaden - Evercore ISI Andrew Kligerman - TD Cowen Cave Montazeri - Deutsche Bank Alex Scott - Barclays Andrew Andersen - Jefferies Meyer Shields - Keefe, Bruyette & Woods Brian Meredith - UBS Operator Good day, ladies and gentlemen, and welcome to the Q4 …

BP Q4 earnings and revenues decline year over year due to lower commodity price realizations and weaker contributions from its customers and products business segment.

Bristol Myers' lackluster guidance for 2025 warrants caution. We recommend investors to wait and watch for the time being as generic competition for legacy drugs is a major headwind.